Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Press Releases

Stock Market Today: S&P 500, Nasdaq Futures Rise As Trump Says Iran War May End 'Within Two Weeks'— Nike, RH, nCino, Beyond Meat In Focus (UPDATED)
Stock Market Today: S&P 500, Nasdaq Futures Rise As Trump Says Iran War May End 'Within Two Weeks'— Nike, RH, nCino, Beyond Meat In Focus (UPDATED)
Bitcoin DeFi Protocol Solv Partners With Stellar To Turn Idle USDC 'Productive' — Next Phase Of Stablecoin Utility?
Bitcoin DeFi Protocol Solv Partners With Stellar To Turn Idle USDC 'Productive' — Next Phase Of Stablecoin Utility?
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
Bitcoin DeFi Protocol Solv Partners With Stellar To Turn Idle USDC 'Productive' — Next Phase Of Stablecoin Utility?
Bitcoin DeFi Protocol Solv Partners With Stellar To Turn Idle USDC 'Productive' — Next Phase Of Stablecoin Utility?
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
Why Did Babcock & Wilcox Stock Jump Nearly 32% In Afterhours Trading?
Why Did Babcock & Wilcox Stock Jump Nearly 32% In Afterhours Trading?
Apple's Key Supplier Foxconn's Gross Profit Hit 7 Year High In Q3, Aims To Expand AI Capabilities By Next Year
Apple's Key Supplier Foxconn's Gross Profit Hit 7 Year High In Q3, Aims To Expand AI Capabilities By Next Year

Press Releases Recent News

California Police Seize $2.3M In Unlicensed Cannabis And Pesticides
California Police Seize $2.3M In Unlicensed Cannabis And Pesticides
California: police seized $2.3M in unlicensed cannabis, highlighting ongoing efforts to protect the legal market.
PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial
PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial
PharmAla Biotech to supply MDMA for a clinical trial at Harvard's Maclean Hospital. Company also explores European distribution at CPHI Milan Conference.
SEC-Approved Cannabis Lender Acquired By Investment Giant, Changes Ticker To $LIEN
SEC-Approved Cannabis Lender Acquired By Investment Giant, Changes Ticker To $LIEN
Chicago Atlantic acquires SEC-approved cannabis lender Silver Spike, renaming it Chicago Atlantic BDC. New ticker $LIEN effective October 2
Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growth
Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growth
Bright Green Corporation addresses Nasdaq delisting, reinforces its commitment to shareholders, and outlines strategic partnerships and growth plans for the future.
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
Awakn Life Sciences expands its private placement to $2 million, closing the fourth tranche with $394,286 raised to accelerate research into addiction treatments.
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop.
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
Drug Science and UCL collaborate to refine MDMA-assisted therapy, addressing FDA concerns and enhancing psychotherapeutic practices for improved treatment outcomes.
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Avicanna secures a U.S. patent for its innovative deep penetrating topical cannabinoid composition for treating pain and inflammation.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved